Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
28.85
-0.19 (-0.65%)
May 30, 2025, 4:00 PM - Market closed

Xenon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-251.45-234.33-182.39-125.37-78.88-28.84
Upgrade
Depreciation & Amortization
2.632.562.061.410.910.64
Upgrade
Other Amortization
-----0.22
Upgrade
Loss (Gain) From Sale of Investments
0.52--3.552.930.72-0
Upgrade
Stock-Based Compensation
53.4950.7232.3720.3810.025.68
Upgrade
Other Operating Activities
-1.52-6.05-5.50.910.390.27
Upgrade
Change in Accounts Receivable
-7.83-0.610.131.76-0.46-1.03
Upgrade
Change in Accounts Payable
9.778.533.938.062.972.02
Upgrade
Change in Unearned Revenue
-----3.64-26.81
Upgrade
Change in Other Net Operating Assets
-2.47-2.21.84-11.1-1.52-0.27
Upgrade
Operating Cash Flow
-196.85-181.39-151.11-101.03-69.5-48.12
Upgrade
Capital Expenditures
-2.93-3.08-5.62-2.89-2.05-2.64
Upgrade
Investment in Securities
245.63168.08-105.77-290.51-244.72-14.19
Upgrade
Investing Cash Flow
242.7165-111.39-293.41-246.77-16.82
Upgrade
Long-Term Debt Repaid
------16.74
Upgrade
Net Debt Issued (Repaid)
------16.74
Upgrade
Issuance of Common Stock
13.2812.13353.52278.47447.54102.54
Upgrade
Financing Cash Flow
13.2812.13353.52278.47447.5485.8
Upgrade
Foreign Exchange Rate Adjustments
-1.37-1.670.38-2.48-0.59-0.59
Upgrade
Net Cash Flow
57.76-5.9391.4-118.45130.6820.25
Upgrade
Free Cash Flow
-199.78-184.46-156.73-103.92-71.55-50.76
Upgrade
Free Cash Flow Margin
-2663.79%---1101.57%-388.09%-157.81%
Upgrade
Free Cash Flow Per Share
-2.56-2.37-2.34-1.72-1.64-1.41
Upgrade
Cash Interest Paid
-----0.34
Upgrade
Levered Free Cash Flow
-128.49-117.59-99.88-54.3-43.76-41.29
Upgrade
Unlevered Free Cash Flow
-128.49-117.59-99.88-54.3-43.76-41.2
Upgrade
Change in Net Working Capital
-1.44-6.77-5.09-7.533.2625.32
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q